GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Total Equity

Control Bionics (ASX:CBL) Total Equity : A$6.46 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Total Equity?

Control Bionics's total equity for the quarter that ended in Dec. 2024 was A$6.46 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Control Bionics Total Equity Historical Data

The historical data trend for Control Bionics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Total Equity Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Total Equity
20.13 17.16 11.92 7.15 6.27

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only 9.72 7.15 7.70 6.27 6.46

Control Bionics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Control Bionics's Total Equity for the fiscal year that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=9.027-2.76
=6.27

Control Bionics's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=8.84-2.381
=6.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Total Equity Related Terms

Thank you for viewing the detailed overview of Control Bionics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Total Equity
Comparable Companies
ASX:ADRDA ASX:AT1 ASX:UCM ASX:HMD ASX:IRX ASX:VTI ASX:LDX ASX:UBI ASX:OSL ASX:EYE ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Website
https://www.controlbionics.com
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.